AAAAAA

   
Results: 1-25 |
Results: 25
Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer
Authors: Simon, R Nocito, A Hubscher, T Bucher, C Torhorst, J Schraml, P Bubendorf, L Mihatsch, MM Moch, H Wilber, K Schotzau, A Kononen, J Sauter, G
Citation: R. Simon et al., Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer, J NAT CANC, 93(15), 2001, pp. 1141-1146
Tissue microarrays: What will they bring to molecular and anatomic pathology?
Authors: Moch, H Kononen, J Kallioniemi, OP Sauter, G
Citation: H. Moch et al., Tissue microarrays: What will they bring to molecular and anatomic pathology?, ADV ANAT PA, 8(1), 2001, pp. 14-20
Tissue microarray technology for high-throughput molecular profiling of cancer
Authors: Kallioniemi, OP Wagner, U Kononen, J Sauter, G
Citation: Op. Kallioniemi et al., Tissue microarray technology for high-throughput molecular profiling of cancer, HUM MOL GEN, 10(7), 2001, pp. 657-662
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nm23-H1 activity
Authors: Forus, A D'Angelo, A Henriksen, J Merla, G Maelandsmo, GM Florenes, VA Olivieri, S Bjerkehagen, B Meza-Zepeda, LA Blanco, FD Muller, C Sanvito, F Kononen, J Nesland, JM Fodstad, O Reymond, A Kallioniemi, OP Arrigoni, G Ballabio, A Myklebost, O Zollo, M
Citation: A. Forus et al., Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nm23-H1 activity, ONCOGENE, 20(47), 2001, pp. 6881-6890
CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors
Authors: Heiskanen, M Kononen, J Barlund, M Torhorst, J Sauter, G Kallioniemi, A Kallioniemi, O
Citation: M. Heiskanen et al., CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors, ANAL CELL P, 22(4), 2001, pp. 229-234
ANX7, a candidate tumor suppressor gene for prostate cancer
Authors: Srivastava, M Bubendorf, L Srikantan, V Fossom, L Nolan, L Glasman, M Leighton, X Fehrle, W Pittaluga, S Raffeld, M Koivisto, P Willi, N Gasser, TC Kononen, J Sauter, G Kallioniemi, OP Srivastava, S Pollard, HB
Citation: M. Srivastava et al., ANX7, a candidate tumor suppressor gene for prostate cancer, P NAS US, 98(8), 2001, pp. 4575-4580
Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer
Authors: Monni, O Barlund, M Mousses, S Kononen, J Sauter, G Heiskanen, M Paavola, P Avela, K Chen, YD Bittner, ML Kallioniemi, A
Citation: O. Monni et al., Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer, P NAS US, 98(10), 2001, pp. 5711-5716
Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade
Authors: Nocito, A Bubendorf, L Tinner, EM Suess, K Wagner, U Forster, T Kononen, J Fijan, A Bruderer, J Schmid, U Ackermann, D Maurer, R Alund, G Knonagel, H Rist, M Anabitarte, M Hering, F Hardmeier, T Schoenenberger, AJ Flury, R Jager, P Fehr, JL Schraml, P Moch, H Mihatsch, MJ Gasser, T Sauter, G
Citation: A. Nocito et al., Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade, J PATHOLOGY, 194(3), 2001, pp. 349-357
Tissue microarrays (TMAs) for high-throughput molecular pathology research
Authors: Nocito, A Kononen, J Kallioniemi, OP Sauter, G
Citation: A. Nocito et al., Tissue microarrays (TMAs) for high-throughput molecular pathology research, INT J CANC, 94(1), 2001, pp. 1-5
Tissue microarrays for rapid linking of molecular changes to clinical endpoints
Authors: Torhorst, J Bucher, C Kononen, J Haas, P Zuber, M Kochli, OR Mross, F Dieterich, H Moch, H Mihatsch, M Kallioniemi, OP Sauter, G
Citation: J. Torhorst et al., Tissue microarrays for rapid linking of molecular changes to clinical endpoints, AM J PATH, 159(6), 2001, pp. 2249-2256
CDKN2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas - Evidence for a second tumor suppressor gene proximal to CDKN2A
Authors: Schraml, P Struckmann, K Bednar, R Fu, WT Gasser, T Wilber, K Kononen, J Sauter, G Mihatsch, MJ Moch, H
Citation: P. Schraml et al., CDKN2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas - Evidence for a second tumor suppressor gene proximal to CDKN2A, AM J PATH, 158(2), 2001, pp. 593-601
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
Authors: Barlund, M Forozan, F Kononen, J Bubendorf, L Chen, YD Bittner, ML Torhorst, J Haas, P Bucher, C Sauter, G Kallioniemi, OP Kallioniemi, A
Citation: M. Barlund et al., Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis, J NAT CANC, 92(15), 2000, pp. 1252-1259
Chromosome imbalances in familial gliomas detected by comparative genomic hybridization
Authors: Paunu, N Sallinen, SL Karhu, R Miettinen, H Sallinen, P Kononen, J Laippala, P Simola, KOJ Helen, P Haapasalo, H
Citation: N. Paunu et al., Chromosome imbalances in familial gliomas detected by comparative genomic hybridization, GENE CHROM, 29(4), 2000, pp. 339-346
Novel findings in gene expression detected in human osteosarcoma by cDNA microarray
Authors: Wolf, M El-Rifai, W Tarkkanen, M Kononen, J Serra, M Eriksen, EF Elomaa, I Kallioniemi, A Kallioniemi, OP Knuutila, S
Citation: M. Wolf et al., Novel findings in gene expression detected in human osteosarcoma by cDNA microarray, CANC GENET, 123(2), 2000, pp. 128-132
Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques
Authors: Sallinen, SL Sallinen, PK Haapasalo, HK Helin, HJ Helen, PT Schraml, P Kallioniemi, OP Kononen, J
Citation: Sl. Sallinen et al., Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques, CANCER RES, 60(23), 2000, pp. 6617-6622
Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression
Authors: Bowen, C Bubendorf, L Voeller, HJ Slack, R Willi, N Sauter, G Gasser, TC Koivisto, P Lack, EE Kononen, J Kallioniemi, OP Gelmann, EP
Citation: C. Bowen et al., Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression, CANCER RES, 60(21), 2000, pp. 6111-6115
Multiple genes at 17q23 undergo amplification and overexpression in breastcancer
Authors: Barlund, M Monni, O Kononen, J Cornelison, R Torhorst, J Sauter, G Kallioniemi, OP Kallioniemi, A
Citation: M. Barlund et al., Multiple genes at 17q23 undergo amplification and overexpression in breastcancer, CANCER RES, 60(19), 2000, pp. 5340-5344
High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer
Authors: Richter, J Wagner, U Kononen, J Fijan, A Bruderer, J Schmid, U Ackermann, D Maurer, R Alund, G Knonagel, H Rist, M Wilber, K Anabitarte, R Hering, F Hardmeier, T Schonenberger, A Flury, R Jager, P Fehr, JL Schraml, P Moch, H Mihatsch, MJ Gasser, T Kallioniemi, OP Sauter, G
Citation: J. Richter et al., High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer, AM J PATH, 157(3), 2000, pp. 787-794
Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and issue microarrays
Authors: Bubendorf, L Kolmer, M Kononen, J Koivisto, P Mousses, S Chen, YD Mahlamaki, E Schraml, P Moch, H Willi, N Elkahloun, AG Pretlow, TG Gasser, TC Mihatsch, MJ Sauter, G Kallioniemi, OP
Citation: L. Bubendorf et al., Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and issue microarrays, J NAT CANC, 91(20), 1999, pp. 1758-1764
Tissue microarrays for gene amplification surveys in many different tumor types
Authors: Schraml, P Kononen, J Bubendorf, L Moch, H Bissig, H Nocito, A Mihatsch, MJ Kallioniemi, OP Sauter, G
Citation: P. Schraml et al., Tissue microarrays for gene amplification surveys in many different tumor types, CLIN CANC R, 5(8), 1999, pp. 1966-1975
CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas
Authors: Miettinen, H Kononen, J Sallinen, P Alho, H Helen, P Helin, H Kalimo, H Paljarvi, L Isola, J Haapasalo, H
Citation: H. Miettinen et al., CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas, J NEURO-ONC, 41(3), 1999, pp. 205-211
A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivatoressential for ligand-dependent transactivation by nuclear receptors in vivo
Authors: Lee, SK Anzick, SL Choi, JE Bubendorf, L Guan, XY Jung, YK Kallioniemi, OP Kononen, J Trent, JM Azorsa, D Jhun, BH Cheong, JH Lee, YC Meltzer, PS Lee, JW
Citation: Sk. Lee et al., A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivatoressential for ligand-dependent transactivation by nuclear receptors in vivo, J BIOL CHEM, 274(48), 1999, pp. 34283-34293
Survey of gene amplifications during prostate cancer progression by high throughput fluorescence in situ hybridization on tissue microarrays
Authors: Bubendorf, L Kononen, J Koivisto, P Schraml, P Moch, H Gasser, TC Willi, N Mihatsch, MJ Sauter, G Kallioniemi, OP
Citation: L. Bubendorf et al., Survey of gene amplifications during prostate cancer progression by high throughput fluorescence in situ hybridization on tissue microarrays, CANCER RES, 59(4), 1999, pp. 803-806
Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas
Authors: Ingvarsson, S Agnarsson, BA Sigbjornsdottir, BI Kononen, J Kallioniemi, OP Barkardottir, RB Kovatich, AJ Schwarting, R Hauck, WW Huebner, K McCue, PA
Citation: S. Ingvarsson et al., Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas, CANCER RES, 59(11), 1999, pp. 2682-2689
High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma
Authors: Moch, H Schraml, P Bubendorf, L Mirlacher, M Kononen, J Gasser, T Mihatsch, MJ Kallioniemi, OP Sauter, G
Citation: H. Moch et al., High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma, AM J PATH, 154(4), 1999, pp. 981-986
Risultati: 1-25 |